Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Buy
59
HTEC Quote, Financials, Valuation and Earnings
Last price:
$29.17
Seasonality move
:
-6.6%
Day range:
$28.99 - $29.22
52-week range:
$25.69 - $30.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.5K
Avg. volume:
11.8K
1-year change:
4.46%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
-- | -- | -- | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.22 | -- | -- | -- | $0.00 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.63 | -- | -- | -- | $0.10 | 0.74% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$9.97 | -- | -- | -- | $0.00 | 0% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$21.82 | -- | -- | -- | $0.06 | 1.13% | -- |
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
$22.83 | -- | -- | -- | $0.11 | 0.98% | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
$24.78 | -- | -- | -- | $0.26 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 2.318 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.252 | -- | -- |
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
-- | 1.497 | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IDNA
iShares Genomics Immunology and Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- | -- |
ROBO Global Healthcare Technology & Innovation ETF vs. Competitors
-
Which has Higher Returns HTEC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Global X Aging Population ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HTEC or AGNG More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HTEC or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About HTEC or GNOM?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is HTEC or GNOM More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.125, suggesting its more volatile than the S&P 500 by 12.532%.
-
Which is a Better Dividend Stock HTEC or GNOM?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or GNOM?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns HTEC or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About HTEC or IBBQ?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is HTEC or IBBQ More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HTEC or IBBQ?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Nasdaq Biotechnology ETF offers a yield of 1.13% to investors and pays a quarterly dividend of $0.06 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or IBBQ?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns HTEC or IDNA?
iShares Genomics Immunology and Healthcare ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat iShares Genomics Immunology and Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- IDNAiShares Genomics Immunology and Healthcare ETF-- -- -- -
What do Analysts Say About HTEC or IDNA?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Genomics Immunology and Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than iShares Genomics Immunology and Healthcare ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than iShares Genomics Immunology and Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 IDNAiShares Genomics Immunology and Healthcare ETF0 0 0 -
Is HTEC or IDNA More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison iShares Genomics Immunology and Healthcare ETF has a beta of 0.981, suggesting its less volatile than the S&P 500 by 1.86%.
-
Which is a Better Dividend Stock HTEC or IDNA?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iShares Genomics Immunology and Healthcare ETF offers a yield of 0.98% to investors and pays a quarterly dividend of $0.11 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. iShares Genomics Immunology and Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or IDNA?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than iShares Genomics Immunology and Healthcare ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than iShares Genomics Immunology and Healthcare ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while iShares Genomics Immunology and Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for iShares Genomics Immunology and Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- IDNAiShares Genomics Immunology and Healthcare ETF-- -- -- --
-
Which has Higher Returns HTEC or MNTL?
Tema Neuroscience and Mental Health ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Tema Neuroscience and Mental Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- MNTLTema Neuroscience and Mental Health ETF-- -- -- -
What do Analysts Say About HTEC or MNTL?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Neuroscience and Mental Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Tema Neuroscience and Mental Health ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Tema Neuroscience and Mental Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 MNTLTema Neuroscience and Mental Health ETF0 0 0 -
Is HTEC or MNTL More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Tema Neuroscience and Mental Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HTEC or MNTL?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tema Neuroscience and Mental Health ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.26 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Tema Neuroscience and Mental Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or MNTL?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Tema Neuroscience and Mental Health ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Tema Neuroscience and Mental Health ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Tema Neuroscience and Mental Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Tema Neuroscience and Mental Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- MNTLTema Neuroscience and Mental Health ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
